Source link : https://www.newshealth.biz/health-news/sglt2s-with-diuretics-improve-heart-failure-outcomes/
LISBON — Patients with acute heart failure on the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin who received diuretic therapy experienced rapid decongestion with shorter hospital stays, report investigators of the ENDORSE-HF trial. Adding dapagliflozin to diuretic therapy in acute heart failure patients “also increases natriuresis and improves the ejection fraction,” said study presenter Ioan Radu […]
Author : News Health
Publish date : 2024-06-07 21:09:37
Copyright for syndicated content belongs to the linked Source.
Categories